Lung carcinomas with EGFR exon 19 insertions are sensitive to gefitinib treatment.
Iyevleva AG, Mitiushkina NV, Karaseva NA, Orlov SV, Volodina LN, Kulikova YE, Lozhkina AM, Ivantsov AO, Tiurin VI, Togo AV, Imyanitov EN.
Iyevleva AG, et al. Among authors: kulikova ye.
J Thorac Oncol. 2014 Apr;9(4):e31-3. doi: 10.1097/JTO.0000000000000106.
J Thorac Oncol. 2014.
PMID: 24736087
Free article.
No abstract available.